SCYNEXIS, Inc. Revenues
SCYNEXIS, Inc. (SCYX) reported Revenues of $64.00 thousand for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-08.
Discontinued › Income Statement › Revenue
us-gaap:Revenues · last filed 2018-05-08
- SCYNEXIS, Inc. revenues for the quarter ending 2018-03-31 was $64.00K, a 0.00% change year-over-year.
- SCYNEXIS, Inc. revenues for the quarter ending 2017-12-31 was $64.00K, a 1.54% decline year-over-year.
- SCYNEXIS, Inc. revenues for the quarter ending 2017-09-30 was $64.00K, a 0.00% change year-over-year.
- SCYNEXIS, Inc. revenues for the quarter ending 2017-06-30 was $64.00K, a 0.00% change year-over-year.
- SCYNEXIS, Inc. revenues for fiscal 2017 was $257.00K, a 0.00% change from fiscal 2016.
- SCYNEXIS, Inc. revenues for fiscal 2016 was $257.00K, a 0.00% change from fiscal 2015.
- SCYNEXIS, Inc. revenues for fiscal 2015 was $257.00K, a 79.54% decline from fiscal 2014.
- SCYNEXIS, Inc. revenues for fiscal 2014 was $1.26M.
| Period end | Revenues 3 month | Revenues 3 month as first filed | Revenues 6 month | Revenues 6 month as first filed | Revenues 9 month | Revenues 9 month as first filed | Revenues 12 month | Revenues 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2018-03-31 | $64.00K 10-Q · filed 2018-05-08 | $128.00K derived: sum of 2 quarters · filed 2018-05-08 | $192.00K derived: sum of 3 quarters · filed 2018-05-08 | $256.00K derived: sum of 4 quarters · filed 2018-05-08 | ||||
| 2017-12-31 | $64.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | $128.00K derived: sum of 2 quarters · filed 2018-03-13 | $192.00K derived: sum of 3 quarters · filed 2018-03-13 | $257.00K 10-K · filed 2018-03-13 | ||||
| 2017-09-30 | $64.00K 10-Q · filed 2017-11-07 | $128.00K derived: sum of 2 quarters · filed 2017-11-07 | $193.00K 10-Q · filed 2017-11-07 | $257.00K derived: sum of 4 quarters · filed 2018-05-08 | ||||
| 2017-06-30 | $64.00K 10-Q · filed 2017-08-08 | $129.00K 10-Q · filed 2017-08-08 | $193.00K derived: sum of 3 quarters · filed 2018-05-08 | $257.00K derived: sum of 4 quarters · filed 2018-05-08 | ||||
| 2017-03-31 | $64.00K 10-Q · filed 2018-05-08 | $129.00K derived: sum of 2 quarters · filed 2018-05-08 | $193.00K derived: sum of 3 quarters · filed 2018-05-08 | $257.00K derived: sum of 4 quarters · filed 2018-05-08 | ||||
| 2016-12-31 | $65.00K 10-K · filed 2017-03-13 | $129.00K derived: sum of 2 quarters · filed 2017-11-07 | $193.00K derived: sum of 3 quarters · filed 2017-11-07 | $257.00K 10-K · filed 2018-03-13 | ||||
| 2016-09-30 | $64.00K 10-Q · filed 2017-11-07 | $128.00K derived: sum of 2 quarters · filed 2017-11-07 | $193.00K 10-Q · filed 2017-11-07 | $256.00K derived: sum of 4 quarters · filed 2017-11-07 | ||||
| 2016-06-30 | $64.00K 10-Q · filed 2017-08-08 | $129.00K 10-Q · filed 2017-08-08 | $192.00K derived: sum of 3 quarters · filed 2017-08-08 | $256.00K derived: sum of 4 quarters · filed 2017-08-08 | ||||
| 2016-03-31 | $64.00K 10-Q · filed 2017-05-08 | $128.00K derived: sum of 2 quarters · filed 2017-05-08 | $192.00K derived: sum of 3 quarters · filed 2017-05-08 | $256.00K derived: sum of 4 quarters · filed 2017-05-08 | ||||
| 2015-12-31 | $64.00K 10-K · filed 2017-03-13 | $128.00K derived: sum of 2 quarters · filed 2017-03-13 | $192.00K derived: sum of 3 quarters · filed 2017-03-13 | $257.00K 10-K · filed 2017-03-13 | ||||
| 2015-09-30 | $64.00K 10-K · filed 2017-03-13 | $128.00K derived: sum of 2 quarters · filed 2017-03-13 | $193.00K 10-Q · filed 2016-11-07 | $1.26M derived: sum of 4 quarters · filed 2017-03-13 | ||||
| 2015-06-30 | $64.00K 10-K · filed 2017-03-13 | $129.00K 10-Q · filed 2016-08-08 | $1.19M derived: sum of 3 quarters · filed 2017-03-13 | $1.25M derived: sum of 4 quarters · filed 2017-03-13 | ||||
| 2015-03-31 | $65.00K 10-K · filed 2017-03-13 | $3.30M 10-Q · filed 2015-05-15 | $1.13M derived: sum of 2 quarters · filed 2017-03-13 | $1.19M derived: sum of 3 quarters · filed 2017-03-13 | $1.25M derived: sum of 4 quarters · filed 2017-03-13 | |||
| 2014-12-31 | $1.06M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | $1.13M derived: sum of 2 quarters · filed 2017-03-13 | $1.19M derived: sum of 3 quarters · filed 2017-03-13 | $1.26M 10-K · filed 2017-03-13 | $19.02M 10-K · filed 2015-03-30 | |||
| 2014-09-30 | $61.00K 10-Q · filed 2015-11-13 | $4.38M 10-Q · filed 2014-11-13 | $126.00K derived: sum of 2 quarters · filed 2015-11-13 | $192.00K 10-Q · filed 2015-11-13 | $13.73M 10-Q · filed 2014-11-13 | -$12.90M derived: sum of 4 quarters · filed 2015-11-13 | ||
| 2014-06-30 | $65.00K 10-Q · filed 2015-08-19 | $4.64M 10-Q · filed 2014-08-13 | $130.00K 10-Q · filed 2015-08-19 | $9.35M 10-Q · filed 2014-08-13 | -$12.96M derived: sum of 3 quarters · filed 2015-10-30 | -$8.80M derived: sum of 4 quarters · filed 2015-10-30 | ||
| 2014-03-31 | $65.00K 8-K · filed 2015-10-30 | $4.71M 10-Q/A · filed 2014-07-11 | -$13.02M derived: sum of 2 quarters · filed 2015-10-30 | -$8.86M derived: sum of 3 quarters · filed 2015-10-30 | -$4.63M derived: sum of 4 quarters · filed 2015-10-30 | |||
| 2013-12-31 | -$13.09M derived: 8-K 12 month − 10-Q 9 month · filed 2015-10-30 | -$8.93M derived: sum of 2 quarters · filed 2015-10-30 | -$4.70M derived: sum of 3 quarters · filed 2015-10-30 | $95.00K 8-K · filed 2015-10-30 | $16.86M 10-K · filed 2015-03-30 | |||
| 2013-09-30 | $4.16M 10-Q · filed 2014-11-13 | $8.39M derived: sum of 2 quarters · filed 2014-11-13 | $13.18M 10-Q · filed 2014-11-13 | |||||
| 2013-06-30 | $4.23M 10-Q · filed 2014-08-13 | $9.02M 10-Q · filed 2014-08-13 | ||||||
| 2013-03-31 | $4.79M 10-Q/A · filed 2014-07-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |